HCW Biologics Inc. announced on November 19, 2025, that it has entered into an agreement to reduce warrant exercise prices, resulting in proceeds of approximately $4.0 million from the immediate exercise of warrants for 1,510,205 shares. The new warrants allow the purchase of 3,020,410 shares at $2.41 each.